超音波內視鏡市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Endoscopic Ultrasound Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月10日 | 出版商:

Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在胃腸道 (GI) 疾病發生率上升和微創診斷程序進步的推動下，全球內視鏡超音波 (EUS) 市場從 2024 年到 2032 年將實現 6.9% 的複合年成長率。據世界衛生組織稱，消化系統疾病是全球發病和死亡的主要原因之一，由於人口老化和生活方式的改變，其盛行率預計將上升。 EUS 是一種結合內視鏡檢查和超音波的混合技術，已成為診斷和分期胃腸道癌症、胰臟疾病和其他疾病的重要工具。 EUS 以其精確性、縮短的恢復時間和較低的併發症風險而得到越來越多的採用，支持了全球市場的擴張。

內視鏡超音波市場根據組件、應用、最終用途和區域進行細分。

在預測期內，針頭部分將在內視鏡超音波市場中取得顯著成長。 EUS 引導下的細針抽吸 (FNA) 和細針活體組織切片 (FNB) 已成為從胰腺和淋巴結等難以接近的區域獲取組織樣本的標準程序。對微創診斷技術（特別是癌症分期和診斷）的需求不斷成長，推動了 EUS 針的採用。針頭設計的創新、靈活性和精確度的提高以及對早期癌症檢測的日益重視都有助於細分市場的成長。

到 2032 年，由於胰臟癌、食道癌和慢性胰臟炎等胃腸道疾病的盛行率不斷上升，胃腸病學領域將主導超音波內視鏡市場。 EUS 正在成為胃腸病學家的首選方法，因為它能夠提供消化道和周圍器官的詳細圖像，促進準確的診斷和治療計劃。胃腸道疾病的增加，加上對侵入性較小的診斷選擇的需求，正在推動 EUS 在胃腸病學中的廣泛使用。

在發達的醫療基礎設施、高額醫療支出以及對癌症篩檢計畫的高度重視的支持下，歐洲內視鏡超音波市場將從 2024 年到 2032 年經歷顯著成長。該地區人口老化，加上胃腸道癌和胰腺癌的高發病率，正在推動對 EUS 等先進診斷工具的需求。此外，旨在早期癌症檢測的政府舉措以及領先醫療設備製造商的存在正在促進整個歐洲 EUS 技術的創新和採用。

產業生態系統分析
產業影響力
- 成長動力
  - 胃腸道疾病發生率上升
  - 技術進步
  - 優惠報銷政策
  - 微創手術的需求不斷增加
- 產業陷阱與挑戰
  - 嚴格的監管框架
  - EUS 設備和程序成本高昂
成長潛力分析
報銷場景
監管環境
技術景觀
未來市場趨勢
管道分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按組成部分，2021 - 2032 年

主要趨勢
內視鏡
- 線性內視鏡
- 徑向內視鏡
針
- 細針抽吸 (FNA) 針
- 細針切片檢查 (FNB) 針
超音波處理器
影像系統
超音波探頭
其他組件

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
腫瘤學
胃腸病學
其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
門診手術中心
其他最終用戶

第 8 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

B.Braun
Boston Scientific Corporation
ConMed
Cook Medical
FUJIFILM Holdings Corporation
HUACO HEALTHCARE TECHNOLOGIES CO. LTD
Medi-Globe Corporation
Medtronic plc
NIHON DEMPA KOGYO CO., LTD.
PENTAX Medical
Philips
SMITH and NEPHEW
SonoScape Medical Corp.
STERIS plc

簡介目錄

Product Code: 10191

Global Endoscopic Ultrasound (EUS) Market will achieve a 6.9% CAGR from 2024 to 2032, driven by the rising incidence of gastrointestinal (GI) disorders and advancements in minimally invasive diagnostic procedures. According to the World Health Organization, digestive diseases are among the leading causes of morbidity and mortality worldwide, with the prevalence expected to rise due to aging populations and lifestyle changes. EUS, a hybrid technique combining endoscopy and ultrasound, has become a crucial tool for diagnosing and staging GI cancers, pancreatic diseases, and other conditions. The growing adoption of EUS for its precision, reduced recovery times, and lower risk of complications supports the expansion of the market globally.

The Endoscopic Ultrasound Market is segmented based on Component, Application, End-use, and Region.

The needle segment will register notable gains in the Endoscopic Ultrasound Market over the forecast period. EUS-guided fine needle aspiration (FNA) and fine needle biopsy (FNB) have become standard procedures for obtaining tissue samples from difficult-to-access areas, such as the pancreas and lymph nodes. The increasing demand for minimally invasive diagnostic techniques, particularly for cancer staging and diagnosis, drives the adoption of EUS needles. Innovations in needle design, enhancing flexibility and precision, and the growing emphasis on early cancer detection contribute to segment growth.

The gastroenterology segment will dominate the Endoscopic Ultrasound Market through 2032, fueled by the increasing prevalence of gastrointestinal diseases, including pancreatic cancer, esophageal cancer, and chronic pancreatitis. EUS is becoming a preferred method for gastroenterologists due to its ability to provide detailed images of the digestive tract and surrounding organs, facilitating accurate diagnosis and treatment planning. The rise in GI disorders, coupled with the demand for less invasive diagnostic options, is driving the widespread use of EUS in gastroenterology.

Europe Endoscopic Ultrasound Market will experience significant growth from 2024 to 2032, supported by a well-developed healthcare infrastructure, high healthcare expenditure, and a strong focus on cancer screening programs. The region's aging population, combined with a high prevalence of gastrointestinal and pancreatic cancers, is driving demand for advanced diagnostic tools like EUS. Furthermore, government initiatives aimed at early cancer detection and the presence of leading medical device manufacturers are fostering innovation and adoption of EUS technology across Europe.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of gastrointestinal diseases
  - 3.2.1.2 Technological advancements
  - 3.2.1.3 Favorable reimbursement policies
  - 3.2.1.4 Increasing demand for minimally invasive procedures
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Stringent regulatory framework
  - 3.2.2.2 High cost of EUS equipment and procedures
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Future market trends
3.8 Pipeline analysis
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Endoscope
- 5.2.1 Linear endoscopes
- 5.2.2 Radial endoscopes
5.3 Needle
- 5.3.1 Fine needle aspiration (FNA) needles
- 5.3.2 Fine needle biopsy (FNB) needles
5.4 Ultrasonic processors
5.5 Imaging systems
5.6 Ultrasound probe
5.7 Other components

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Oncology
6.3 Gastroenterology
6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa